Research Overview: Mildronate
Mildronate 500mg represents a pharmaceutical-grade meldonium formulation manufactured by Grindex for in-vitro laboratory investigations. Meldonium is a structural analogue of gamma-butyrobetaine that functions as a competitive inhibitor of carnitine biosynthesis. Researchers at Stroid UK Shop utilise this compound to examine metabolic pathways and cardioprotective mechanisms in controlled laboratory environments. The compound’s unique molecular structure enables selective modulation of fatty acid oxidation pathways, making it valuable for studying cellular energy metabolism and ischaemic preconditioning responses.
Laboratory Applications
Research scientists investigate mildronate’s effects on carnitine-dependent metabolic processes and cellular energy production. The compound demonstrates particular utility in studies examining cardiac tissue protection mechanisms and metabolic adaptation responses. Laboratory models show mildronate’s capacity to shift cellular metabolism from fatty acid oxidation toward glucose utilisation, providing insights into metabolic flexibility. Researchers studying cardiovascular pathophysiology find this compound valuable for examining protective mechanisms against ischaemic stress. The formulation enables precise dosing control in experimental protocols, complementing other research compounds available in our meldonium category alongside investigations involving SARMs and peptides.
Specifications
| Parameter | Value |
|---|---|
| Active Compound | Meldonium (Mildronate) |
| Strength | 500mg per tablet |
| Manufacturer | Grindex |
| CAS Number | 76144-81-5 |
| Molecular Formula | C₆H₁₄N₂O₂ |
| Molecular Weight | 146.19 g/mol |
| Storage | Room temperature, dry conditions |
Research Compliance
This product is manufactured specifically for laboratory research purposes and in-vitro applications only. Mildronate 500mg tablets are intended solely for qualified researchers conducting studies on metabolic pathways, cardioprotective mechanisms, and cellular energy metabolism. Not approved for human consumption or therapeutic use. Researchers must ensure appropriate laboratory protocols and safety measures when handling this compound.
